Treatment of pectoralis major flap myospasms with botulinum toxin type A in head and neck reconstruction.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 22071458.
- Also identified by DOI 10.1016/j.bjps.2011.10.002.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Treatment options for muscle spasm complications of the pectoralis major (PM) flap in head and neck reconstruction have hardly been investigated. The authors report their experience using botulinum toxin (BTX-A) injections as a treatment of PM flap myospasm complications in head and neck reconstruction. From January 2005 to May 2009, 83 patients underwent PM flap reconstruction. Eleven of them reported muscle twitching as a post-operative complication and are therefore included in this study. As all 11 patients refused a second surgery, they were offered BTX-A injections. This group of patients was followed up at regular intervals with clinical examinations, digital photography, range of motion (ROM) of the neck in different vectors, and neck disability system (NDS) questionnaires. After the first BTX-A infiltration, muscle twitching decreased, the ROM values increased and, according to the NDS, patients' discomfort progressively decreased. Only two of the 11 patients required two additional BTX-A sessions. BTX-A infiltration is an effective non-invasive procedure that significantly reduces the PM muscular contraction in head and neck reconstruction.
Medical subject headings
- Botulinum Toxins, Type A
- Pectoralis Muscles
- Plastic Surgery Procedures
- Spasm
- Surgical Flaps
- Transplant Donor Site